Marjorie Gillespie

Statistics

Publications

Citations

1.9K

H-Index

Active since

1935

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

Western Infirmary

Marjorie Gillespie is an author at National Institute of Neurological Disorders and Stroke specializing in medicine, neuropharmacology, and pharmacology.

Publications per year

1935–2022

Publications

T-Cell Proliferation Involving the CD28 Pathway Is Associated witH Cyclosporine-Resistant Interleukin 2 Gene Expression

Carl H. June, Jeffrey A. Ledbetter, Marjorie Gillespie et al. · Molecular and Cellular Biology · 1987 · 526 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Adenosine A <sub>2A</sub> receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

Medicine, Pharmacology, Pharmacotherapy +17

Huntington’s disease

Leo Verhagen Metman, Michael J. Morris, Cristan Farmer et al. · Neurology · 2002 · 162 citations

Medicine, Neurology, Pharmacology +17

BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM

Ronald Kartzinel, Paul F. Teychenné, Marjorie Gillespie et al. · The Lancet · 1976 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +14

RENAL LESIONS IN TWO CASES OF CRUSH SYNDROME

John Shaw Dunn, Marjorie Gillespie, J. S. F. Niven · The Lancet · 1941 · 93 citations

Medicine, Nephrology, Pathology +8

1–5 of 19